These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 9443730)
1. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730 [TBL] [Abstract][Full Text] [Related]
2. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. Khan N; Oriuchi N; Zhang H; Higuchi T; Tian M; Inoue T; Sato N; Endo K Nucl Med Commun; 2003 Apr; 24(4):359-66. PubMed ID: 12673163 [TBL] [Abstract][Full Text] [Related]
4. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. Inokuma T; Tamaki N; Torizuka T; Fujita T; Magata Y; Yonekura Y; Ohshio G; Imamura M; Konishi J J Nucl Med; 1995 Feb; 36(2):229-35. PubMed ID: 7830119 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. Tatsumi M; Yutani K; Watanabe Y; Miyoshi S; Tomiyama N; Johkoh T; Kusuoka H; Nakamura H; Nishimura T J Nucl Med; 1999 Apr; 40(4):566-73. PubMed ID: 10210214 [TBL] [Abstract][Full Text] [Related]
6. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. Lu P; Sun Y; Sun Y; Yu L Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198 [TBL] [Abstract][Full Text] [Related]
9. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging. Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482 [TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152 [TBL] [Abstract][Full Text] [Related]
11. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M Respiration; 2003; 70(5):500-6. PubMed ID: 14665776 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747 [TBL] [Abstract][Full Text] [Related]
13. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals. Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098 [TBL] [Abstract][Full Text] [Related]
14. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET. Tatsumi M; Yutani K; Nishimura T J Comput Assist Tomogr; 2000; 24(4):574-80. PubMed ID: 10966189 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. Demura Y; Tsuchida T; Ishizaki T; Mizuno S; Totani Y; Ameshima S; Miyamori I; Sasaki M; Yonekura Y J Nucl Med; 2003 Apr; 44(4):540-8. PubMed ID: 12679397 [TBL] [Abstract][Full Text] [Related]
17. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers. Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997 [TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. Hara T; Inagaki K; Kosaka N; Morita T J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of FDG PET in patients with cervical cancer. Sugawara Y; Eisbruch A; Kosuda S; Recker BE; Kison PV; Wahl RL J Nucl Med; 1999 Jul; 40(7):1125-31. PubMed ID: 10405131 [TBL] [Abstract][Full Text] [Related]
20. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET). Schmid RA; Hautmann H; Poellinger B; Kellner W; Moisseev A; Brinkbaeumer K; Weiss M; Hahn K; Dresel S Nucl Med Commun; 2003 Jan; 24(1):37-45. PubMed ID: 12501018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]